Immix Biopharma
IMMX
IMMX
23 hedge funds and large institutions have $6.32M invested in Immix Biopharma in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Holders
23
Holding in Top 10
–
Calls
$25K
Puts
$2K
Top Buyers
| 1 | +$63K | |
| 2 | +$38.6K | |
| 3 | +$17.7K | |
| 4 |
Morgan Stanley
New York
|
+$14.8K |
| 5 |
BlackRock
New York
|
+$161 |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$164K | |
| 3 | -$40.2K | |
| 4 |
TW
TritonPoint Wealth
Chevy Chase,
Maryland
|
-$38.3K |
| 5 |
Millennium Management
New York
|
-$32.1K |